Strategic Financing Leverage Indivior PLC’s recent financing activity and dividend strategy to position Lathian Systems as a trusted partner for financial operations, ERP scale, and compliance tooling that can support treasury, risk management, and investor relations workflows.

Revenue Signals With reported quarterly revenue of 343 million and a broad pharmaceutical footprint, target non-core manufacturing or contract development and manufacturing opportunities that align with Indivior’s global scale while offering cost efficiencies and quality assurance enhancements.

Opioid Use Disorder Focus Capitalize on Indivior’s emphasis on opioid use disorder treatment by offering R&D data management, regulated manufacturing compliance, and post-market analytics solutions that strengthen clinical trial data integrity and pharmacovigilance.

Partnership Footprint Identify collaboration opportunities across government and large health programs, given past VA contract activity and VA Tech partnerships, by proposing integrated manufacturing, supply chain visibility, and audit-ready processes tailored to public sector procurement.

Tech Stack Fit Position Lathian Systems as a solutions provider compatible with Indivior’s existing tech stack (SharePoint, Salesforce, AuditBoard, Minitab) to deliver seamless document control, audit readiness, data analytics, and CRM-enabled manufacturing operations.